Allergic rhinitis (AR) represents a global health concern where it affects approximately 400
million people worldwide. The prevalence of AR has increased over the years along with …

In the past few decades, the prevalence of allergic diseases has increased worldwide. Here,
we review the etiology and pathophysiology of allergic diseases, including the role of the …

Background Allergoid–mannan conjugates are novel vaccines for allergen-specific
immunotherapy being currently assayed in phase 2 clinical trials. Allergoid–mannan …

Allergic rhinitis is caused by a breakdown of the Th1/Th2 balance, in which the allergen-
induced Th2 immune response predominates over the Th1 immune response, culminating …

In the last few decades, there has been a progressive increase in the prevalence of allergic
rhinitis (AR) in China, where it now affects approximately 250 million people. AR prevention …

Abstract Background: Allergic rhinitis (AR), an IgE mediated inflammatory disease,
significantly impacts quality of life of a considerable proportion of the general population …

Allergic rhinitis (AR) is a common rhinopathy that affects up to 30% of the adult population. It
is defined as an inflammation of the nasal mucosa, develops in allergic individuals, and is …

Background Inconsistencies remain regarding the effectiveness and safety of leukotriene
receptor antagonists (LTRAs) and selective H1-antihistamines (SAHs) for allergic rhinitis …

Allergic rhinitis (AR) is the most common allergic disease worldwide and one of the most
common chronic diseases in general. Allergic rhinitis is caused by inhalant allergens from …

Allergic rhinitis is a highly prevalent disease affecting the quality of life of millions of patients.
Immunotherapy, medication, and allergen avoidance are all part of the treatment for allergic …